Strong Trading Conditions in International Plasma Therapies

Strong Trading Conditions in International Plasma Therapies

Melbourne, Australia — 13/12/2006

CSL Limited today lifted its financial guidance for the 2006/2007 financial year following strong trading conditions in the international plasma therapies market.

The company now expects a net profit after tax of between $440m and $460m, an increase of approximately 10% above guidance provided at the 2006 full year result announcement in August of this year.

This revised guidance is subject to currency fluctuation, material price movements in core plasma products and the effective tax rate.

Download this release: PDF icon Strong Trading Conditions in International Plasma Therapies

For further information, please contact:
Mark Dehring
Head of Investor Relations
CSL Limited Telephone: +613 9389 2818
© 2016 CSL Limited